Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility

Irfan A. Qureshi, Mark F. Mehler

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

There are numerous examples of sex differences in brain and behavior and in susceptibility to a broad range of brain diseases. For example, gene expression is sexually dimorphic during brain development, adult life, and aging. These differences are orchestrated by the interplay between genetic, hormonal, and environmental influences. However, the molecular mechanisms that underpin these differences have not been fully elucidated. Because recent studies have highlighted the key roles played by epigenetic processes in regulating gene expression and mediating brain form and function, this chapter reviews emerging evidence that shows how epigenetic mechanisms including DNA methylation, histone modifications, and chromatin remodeling, and non-coding RNAs (ncRNAs) are responsible for promoting sexual dimorphism in the brain. Differential profiles of DNA methylation and histone modifications are found in dimorphic brain regions such as the hypothalamus as a result of sex hormone exposure during developmental critical periods. The elaboration of specific epigenetic marks is also linked with regulating sex hormone signaling pathways later in life. Furthermore, the expression and function of epigenetic factors such as the methyl-CpG-binding protein, MeCP2, and the histone-modifying enzymes, UTX and UTY, are sexually dimorphic in the brain. ncRNAs are also implicated in promoting sex differences. For example, X inactivation-specific transcript (. XIST) is a long ncRNA that mediates X chromosome inactivation, a seminal developmental process that is particularly important in brain. These observations imply that understanding epigenetic mechanisms, which regulate dimorphic gene expression and function, is necessary for developing a more comprehensive view of sex differences in brain. These emerging findings also suggest that epigenetic mechanisms are, in part, responsible for the differential susceptibility between males and females that is characteristic of a spectrum of neurological and psychiatric disorders.

Original languageEnglish (US)
Pages (from-to)77-95
Number of pages19
JournalProgress in Brain Research
Volume186
Issue numberC
DOIs
StatePublished - 2010

Fingerprint

Disease Susceptibility
Epigenomics
Sex Characteristics
Psychiatry
Brain
Histone Code
X Chromosome Inactivation
Untranslated RNA
Gonadal Steroid Hormones
DNA Methylation
Gene Expression
Genetic Epigenesis
Long Noncoding RNA
Chromatin Assembly and Disassembly
Brain Diseases
Nervous System Diseases
Histones
Hypothalamus
Carrier Proteins
Enzymes

Keywords

  • DNA methylation
  • Epigenetics
  • Histone modifications
  • MicroRNAs
  • Non-coding RNAs
  • Sex differences
  • X chromosome inactivation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

@article{ce4b266a3f644493b434ef0440acd165,
title = "Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility",
abstract = "There are numerous examples of sex differences in brain and behavior and in susceptibility to a broad range of brain diseases. For example, gene expression is sexually dimorphic during brain development, adult life, and aging. These differences are orchestrated by the interplay between genetic, hormonal, and environmental influences. However, the molecular mechanisms that underpin these differences have not been fully elucidated. Because recent studies have highlighted the key roles played by epigenetic processes in regulating gene expression and mediating brain form and function, this chapter reviews emerging evidence that shows how epigenetic mechanisms including DNA methylation, histone modifications, and chromatin remodeling, and non-coding RNAs (ncRNAs) are responsible for promoting sexual dimorphism in the brain. Differential profiles of DNA methylation and histone modifications are found in dimorphic brain regions such as the hypothalamus as a result of sex hormone exposure during developmental critical periods. The elaboration of specific epigenetic marks is also linked with regulating sex hormone signaling pathways later in life. Furthermore, the expression and function of epigenetic factors such as the methyl-CpG-binding protein, MeCP2, and the histone-modifying enzymes, UTX and UTY, are sexually dimorphic in the brain. ncRNAs are also implicated in promoting sex differences. For example, X inactivation-specific transcript (. XIST) is a long ncRNA that mediates X chromosome inactivation, a seminal developmental process that is particularly important in brain. These observations imply that understanding epigenetic mechanisms, which regulate dimorphic gene expression and function, is necessary for developing a more comprehensive view of sex differences in brain. These emerging findings also suggest that epigenetic mechanisms are, in part, responsible for the differential susceptibility between males and females that is characteristic of a spectrum of neurological and psychiatric disorders.",
keywords = "DNA methylation, Epigenetics, Histone modifications, MicroRNAs, Non-coding RNAs, Sex differences, X chromosome inactivation",
author = "Qureshi, {Irfan A.} and Mehler, {Mark F.}",
year = "2010",
doi = "10.1016/B978-0-444-53630-3.00006-3",
language = "English (US)",
volume = "186",
pages = "77--95",
journal = "Progress in Brain Research",
issn = "0079-6123",
publisher = "Elsevier",
number = "C",

}

TY - JOUR

T1 - Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility

AU - Qureshi, Irfan A.

AU - Mehler, Mark F.

PY - 2010

Y1 - 2010

N2 - There are numerous examples of sex differences in brain and behavior and in susceptibility to a broad range of brain diseases. For example, gene expression is sexually dimorphic during brain development, adult life, and aging. These differences are orchestrated by the interplay between genetic, hormonal, and environmental influences. However, the molecular mechanisms that underpin these differences have not been fully elucidated. Because recent studies have highlighted the key roles played by epigenetic processes in regulating gene expression and mediating brain form and function, this chapter reviews emerging evidence that shows how epigenetic mechanisms including DNA methylation, histone modifications, and chromatin remodeling, and non-coding RNAs (ncRNAs) are responsible for promoting sexual dimorphism in the brain. Differential profiles of DNA methylation and histone modifications are found in dimorphic brain regions such as the hypothalamus as a result of sex hormone exposure during developmental critical periods. The elaboration of specific epigenetic marks is also linked with regulating sex hormone signaling pathways later in life. Furthermore, the expression and function of epigenetic factors such as the methyl-CpG-binding protein, MeCP2, and the histone-modifying enzymes, UTX and UTY, are sexually dimorphic in the brain. ncRNAs are also implicated in promoting sex differences. For example, X inactivation-specific transcript (. XIST) is a long ncRNA that mediates X chromosome inactivation, a seminal developmental process that is particularly important in brain. These observations imply that understanding epigenetic mechanisms, which regulate dimorphic gene expression and function, is necessary for developing a more comprehensive view of sex differences in brain. These emerging findings also suggest that epigenetic mechanisms are, in part, responsible for the differential susceptibility between males and females that is characteristic of a spectrum of neurological and psychiatric disorders.

AB - There are numerous examples of sex differences in brain and behavior and in susceptibility to a broad range of brain diseases. For example, gene expression is sexually dimorphic during brain development, adult life, and aging. These differences are orchestrated by the interplay between genetic, hormonal, and environmental influences. However, the molecular mechanisms that underpin these differences have not been fully elucidated. Because recent studies have highlighted the key roles played by epigenetic processes in regulating gene expression and mediating brain form and function, this chapter reviews emerging evidence that shows how epigenetic mechanisms including DNA methylation, histone modifications, and chromatin remodeling, and non-coding RNAs (ncRNAs) are responsible for promoting sexual dimorphism in the brain. Differential profiles of DNA methylation and histone modifications are found in dimorphic brain regions such as the hypothalamus as a result of sex hormone exposure during developmental critical periods. The elaboration of specific epigenetic marks is also linked with regulating sex hormone signaling pathways later in life. Furthermore, the expression and function of epigenetic factors such as the methyl-CpG-binding protein, MeCP2, and the histone-modifying enzymes, UTX and UTY, are sexually dimorphic in the brain. ncRNAs are also implicated in promoting sex differences. For example, X inactivation-specific transcript (. XIST) is a long ncRNA that mediates X chromosome inactivation, a seminal developmental process that is particularly important in brain. These observations imply that understanding epigenetic mechanisms, which regulate dimorphic gene expression and function, is necessary for developing a more comprehensive view of sex differences in brain. These emerging findings also suggest that epigenetic mechanisms are, in part, responsible for the differential susceptibility between males and females that is characteristic of a spectrum of neurological and psychiatric disorders.

KW - DNA methylation

KW - Epigenetics

KW - Histone modifications

KW - MicroRNAs

KW - Non-coding RNAs

KW - Sex differences

KW - X chromosome inactivation

UR - http://www.scopus.com/inward/record.url?scp=78649277821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649277821&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-53630-3.00006-3

DO - 10.1016/B978-0-444-53630-3.00006-3

M3 - Article

C2 - 21094887

AN - SCOPUS:78649277821

VL - 186

SP - 77

EP - 95

JO - Progress in Brain Research

JF - Progress in Brain Research

SN - 0079-6123

IS - C

ER -